logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: $140 million in Q2 vs. -$689 million in the same period last year.
-EPS: $0.13 in Q2 vs. -$0.63 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $605 million or $0.55 per share for the period.
-Analysts projected $0.53 per share
-Revenue: $3.87 billion in Q2 vs. $4.18 billion in the same period last year.

-Guidance:
Full year EPS guidance: $2.30 - $2.55
Full year revenue guidance: $16.6 - $17 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT